633312-86-4 Usage
General Description
2-(3,4-Difluorophenyl)cyclopropaneamine is a chemical compound with the molecular formula C9H11F2N. It is a cyclopropane derivative with a phenyl and an amine group attached to it. 2-(3,4-Difluorophenyl)cyclopropaneamine is often used as a building block in organic synthesis, particularly in the pharmaceutical industry for the production of various drugs. It has also been studied for its potential biological and pharmacological activities, including its role as a serotonin receptor agonist and its potential use in the treatment of various mental health disorders. Additionally, its unique cyclopropane structure makes it an interesting target for medicinal chemistry research.
Check Digit Verification of cas no
The CAS Registry Mumber 633312-86-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,3,3,1 and 2 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 633312-86:
(8*6)+(7*3)+(6*3)+(5*3)+(4*1)+(3*2)+(2*8)+(1*6)=134
134 % 10 = 4
So 633312-86-4 is a valid CAS Registry Number.
633312-86-4Relevant articles and documents
A process for preparing (1 R, 2 S) - 2 - (3, 4 - difluorophenyl) amine method
-
, (2018/01/11)
The invention relates to a method for preparation of (1R,2S)-2-(3,4-difluorophenyl)cyclopropylamine represented by the formula I. The method adopts 1-(3,4-difluorophenyl)ethylene as a raw material, a dextro-laevo isomer of the formula I is obtained succes
Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
-
, (2008/06/13)
The invention relates to a novel process for the preparation of certain cyclopropyl carboxylic acid esters and other cyclopropyl carboxylic acid derivatives; a novel process for the preparation of dimethylsulfoxonium methylide and dimethylsulfonium methylide; to the use of certain cyclopropyl carboxylic acid esters in a process for the preparation of intermediates that can be used in the synthesis of pharmaceutically active entities; and to certain intermediates provided by these processes.
